In Brief: Ephedrine letter
This article was originally published in The Tan Sheet
Executive Summary
Ephedrine letter: FDA sends April 17 warning letter to Bowling Green, Ky.-based Roman Pharmacraft for promoting its products containing ephedrine HCl as stimulants. FDA also cited the firm for marketing a phenylpropanolamine-containing diet aid that is not in a dosage form deferred from regulation by FDA...